New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Published Jun 18, 2020

New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Checkpoint inhibitor OPDIVO has shown tremendous promise for patients battling advanced esophageal cancer. An expert tells SurvivorNet that in esophageal cancer, anything that improves survival in patients whose disease already progresses after chemotherapy is remarkable.

NOW
PLAYING
FDA: Risks to Myeloma Patients Taking Pepaxto After Deaths in Trial
NOW
PLAYING
FDA Approves Combination of Keytruda & Lenvima For Treatment Of Advanced Uterine Cancer: What Women Need To Know
NOW
PLAYING
Remembering 'Top Chef's' Fatima Ali, Who Passed 2 Years Ago From Cancer: Has There Been Any Progress On Ewing Sarcoma Since?
NOW
PLAYING
First Melanoma Patient Gets mRNA Cancer Vaccine From Medical Company That Cracked COVID; How Does mRNA Work?
NOW
PLAYING
87% of Eligible Patients Skip Lung Cancer Screening, Analysis Finds
NOW
PLAYING
Do You Have a Question About Mental Health & Cancer-- Ask Dr. Strongin-- A New Column From SurvivorNet

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.